As of May 2023, Ozempic and Wegovy are both listed on FDAs Drug Shortages list . When reached for comment on the matter, Novo Nordisk pointed to this press release concerning its recent filing of trademark infringement and false advertising suits against certain medical spas, weight loss or wellness clinics, and compounding pharmacies, that it alleges are unlawfully using its trademarked brand names Ozempic or Wegovy when marketing and/or selling compounded products purporting to contain semaglutide that are not genuine Ozempic or Wegovy products
These effects are generally minor and resolve without intervention
Mahdavifard S, Nakhjavani M
In this Review, we highlight the many facets of normal and pathological feeding behaviour and body weight regulation and suggest that these provide a framework with which to develop integrative methods to study, and ultimately treat, EDs
" GLP-1 "
After week 4, the side effect burden decreases dramatically for the majority of patients, and benefits like sustained weight loss and improved blood sugar control become more apparent